HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Oramed Pharmaceuticals (NASDAQ:ORMP) from Buy to Neutral.
Societe Generale Maintains Buy on Intl Flavors & Fragrances, Lowers Price Target to $145
Societe Generale analyst Thomas Swoboda maintains Intl Flavors & Fragrances (NYSE:IFF) with a Buy and lowers the price target from $170 to $145.